BRCC3 acts as a prognostic marker in nasopharyngeal carcinoma patients treated with radiotherapy and mediates radiation resistance in vitro

BACKGROUND: BRCC3 has been found to be aberrantly expressed in breast tumors and involved in DNA damage response. The contribution of BRCC3 to nasopharyngeal carcinoma prognosis and radiosensitivity is still unclear. METHODS: Immunohistochemical analysis of BRCC3 was carried out in 100 nasopharyngea...

Descripción completa

Detalles Bibliográficos
Autores principales: Tu, Ziwei, Xu, Bingqing, Qu, Chen, Tao, Yalan, Chen, Chen, Hua, Wenfeng, Feng, Guokai, Chang, Hui, Liu, Zhigang, Li, Guo, Jiang, Changbin, Yi, Wei, Zeng, Musheng, Xia, Yunfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511524/
https://www.ncbi.nlm.nih.gov/pubmed/26024915
http://dx.doi.org/10.1186/s13014-015-0427-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511524/
https://www.ncbi.nlm.nih.gov/pubmed/26024915
http://dx.doi.org/10.1186/s13014-015-0427-3

Ejemplares similares